ArticleCell cycle (Georgetown, Tex.)2017

The CDK4/6 inhibitor palbociclib synergizes with irinotecan to promote colorectal cancer cell death under hypoxia.

Jun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.